| MIDAS | microphthalmia-dermal aplasia-sclerocornea [syndrome]; Multicenter Isradipine Diuretic Arteriosclero... |
|---|---|
| Tabs | tablets |
| ISR | Isradipine |
|---|---|
| MIDAS | MULTICENTER ISRADIPINE/DIURETIC ATHEROSCLEROSIS STUDY |
| isradipine | <chemical> 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methyl ethyl ester. A potent calcium channel antagonist that is highly selective for vascular smooth muscle. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure. Pharmacological action: antihypertensive agents, calcium channel blockers, vasodilator agents. Chemical name: 3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester (12 Dec 1998) |
|---|---|
| tablets | Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (12 Dec 1998) |
| tablets, enteric-coated | Tablets coated with material that delays release of the medication until after they leave the stomach. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|